Latest News about Ocugen Inc/
Recent news which mentions Ocugen Inc/
Lab Notes: Imvax advances brain cancer treatment; Wistar identifies promising compound for HIV patients
March 31, 2023
Tickers
INNO
From Business Journals
Tickers
INNO
From Business Journals
Tickers
INNO
From Business Journals
Lab Notes: Drexel and Bancroft team up to advance autism research; AmerisourceBergen forms new partnership
February 03, 2023
Tickers
INNO
From Business Journals
Lab Notes: Neuronetics resolves lawsuit; Harmony CEO departs; Ocugen issues results of Covaxin study
January 13, 2023
Tickers
INNO
From Business Journals
Lab Notes: Chimeron Bio names new CEO; Amicus Therapeutics gets positive opinion for rare disease therapy
December 23, 2022
Tickers
INNO
From Business Journals
Lab Notes: Cabaletta signs licensing deal for up to $162M; merger unites life sciences tech providers
October 14, 2022
Tickers
INNO
From Business Journals
Lab Notes: Integral Molecular has first submission for new FDA pilot program; Jefferson ALS program expanding
September 09, 2022
Tickers
INNO
From Business Journals
Ocugen's efforts to bring Covid-19 vaccine Covaxin to U.S. boosted by positive study results in children
June 21, 2022
From Business Journals
Lab Notes: Endo gets U.S. rights to potential knee pain drug; Optinose stock climbs after positive study results
June 17, 2022
Tickers
INNO
From Business Journals
From Business Journals
Ocugen's study of Covid-19 vaccine Covaxin put on hold in wake of WHO inspection of Bharat
April 12, 2022
From Business Journals
Lab Notes: Venatorx closes Series C financing; Ocugen takes 'critical' step in clinical trial
April 08, 2022
Tickers
INNO
From Business Journals
Lab Notes: Chimeron's Covid-19 vaccine candidate shows promise; Lannett gets 2nd NYSE delisting notice
March 25, 2022
Tickers
INNO
From Business Journals
From Business Journals
From Business Journals
From Business Journals
Lab Notes: Strata Skin Sciences makes acquisition; Cabaletta Bio promotes 2 executives
January 14, 2022
Tickers
INNO
From Business Journals
Tickers
INNO
From Business Journals
FDA places a hold on Ocugen's plan for U.S. trials of the Covid-19 vaccine Covaxin
November 30, 2021
From Business Journals
Ocugen applies for emergency FDA authorization for use of its Covid-19 vaccine in children
November 05, 2021
From Business Journals
Lab Notes: Trice gets FDA approval for device; Ocugen files to begin Covid-19 vaccine trial
October 29, 2021
Tickers
INNO
From Business Journals
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.